619 related articles for article (PubMed ID: 29684591)
1. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
[TBL] [Abstract][Full Text] [Related]
2. Cyclopeptide Dmt-[D-Lys-p-CF
Piekielna-Ciesielska J; Ferrari F; Calo' G; Janecka A
Peptides; 2018 Mar; 101():227-233. PubMed ID: 29196181
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF
Piekielna-Ciesielska J; Mollica A; Pieretti S; Fichna J; Szymaszkiewicz A; Zielińska M; Kordek R; Janecka A
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):560-566. PubMed ID: 29513114
[TBL] [Abstract][Full Text] [Related]
4. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
7. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation.
Piekielna-Ciesielska J; Artali R; Azzam AAH; Lambert DG; Kluczyk A; Gentilucci L; Janecka A
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375124
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery.
Kokubu S; Eddinger KA; Nguyen TM; Huerta-Esquivel LL; Yamaguchi S; Schiller PW; Yaksh TL
Scand J Pain; 2019 Jan; 19(1):193-206. PubMed ID: 30367811
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues.
Perlikowska R; Malfacini D; Cerlesi MC; Calo' G; Piekielna J; Floriot L; Henry T; do-Rego JC; Tömböly C; Kluczyk A; Janecka A
Peptides; 2014 May; 55():145-50. PubMed ID: 24632335
[TBL] [Abstract][Full Text] [Related]
12. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
13. Novel 2',6'-dimethyl-L-tyrosine-containing pyrazinone opioid mimetic mu-agonists with potent antinociceptive activity in mice.
Jinsmaa Y; Okada Y; Tsuda Y; Shiotani K; Sasaki Y; Ambo A; Bryant SD; Lazarus LH
J Pharmacol Exp Ther; 2004 Apr; 309(1):432-8. PubMed ID: 14718580
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
[TBL] [Abstract][Full Text] [Related]
15. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
16. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.
DeWire SM; Yamashita DS; Rominger DH; Liu G; Cowan CL; Graczyk TM; Chen XT; Pitis PM; Gotchev D; Yuan C; Koblish M; Lark MW; Violin JD
J Pharmacol Exp Ther; 2013 Mar; 344(3):708-17. PubMed ID: 23300227
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
Giri AK; Apostol CR; Wang Y; Forte BL; Largent-Milnes TM; Davis P; Rankin D; Molnar G; Olson KM; Porreca F; Vanderah TW; Hruby VJ
J Med Chem; 2015 Nov; 58(21):8573-83. PubMed ID: 26465170
[TBL] [Abstract][Full Text] [Related]
19. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.
Schuster DJ; Metcalf MD; Kitto KF; Messing RO; Fairbanks CA; Wilcox GL
Br J Pharmacol; 2015 Jan; 172(2):642-53. PubMed ID: 24827408
[TBL] [Abstract][Full Text] [Related]
20. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.
Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW
ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]